181 related articles for article (PubMed ID: 29107270)
1. Prediagnostic Risk Assessment with Prostate MRI and MRI-Targeted Biopsy.
Bjurlin MA; Taneja SS
Urol Clin North Am; 2017 Nov; 44(4):535-546. PubMed ID: 29107270
[TBL] [Abstract][Full Text] [Related]
2. Relationship Between Prebiopsy Multiparametric Magnetic Resonance Imaging (MRI), Biopsy Indication, and MRI-ultrasound Fusion-targeted Prostate Biopsy Outcomes.
Meng X; Rosenkrantz AB; Mendhiratta N; Fenstermaker M; Huang R; Wysock JS; Bjurlin MA; Marshall S; Deng FM; Zhou M; Melamed J; Huang WC; Lepor H; Taneja SS
Eur Urol; 2016 Mar; 69(3):512-7. PubMed ID: 26112001
[TBL] [Abstract][Full Text] [Related]
3. Role of MRI prebiopsy in men at risk for prostate cancer: taking off the blindfold.
Bjurlin MA; Rosenkrantz AB; Taneja SS
Curr Opin Urol; 2017 May; 27(3):246-253. PubMed ID: 28234749
[TBL] [Abstract][Full Text] [Related]
4. Risk Stratification by Urinary Prostate Cancer Gene 3 Testing Before Magnetic Resonance Imaging-Ultrasound Fusion-targeted Prostate Biopsy Among Men With No History of Biopsy.
Fenstermaker M; Mendhiratta N; Bjurlin MA; Meng X; Rosenkrantz AB; Huang R; Deng FM; Zhou M; Huang WC; Lepor H; Taneja SS
Urology; 2017 Jan; 99():174-179. PubMed ID: 27562202
[TBL] [Abstract][Full Text] [Related]
5. The value of magnetic resonance imaging and ultrasonography (MRI/US)-fusion biopsy platforms in prostate cancer detection: a systematic review.
Gayet M; van der Aa A; Beerlage HP; Schrier BP; Mulders PF; Wijkstra H
BJU Int; 2016 Mar; 117(3):392-400. PubMed ID: 26237632
[TBL] [Abstract][Full Text] [Related]
6. Comparison of systematic transrectal biopsy to transperineal magnetic resonance imaging/ultrasound-fusion biopsy for the diagnosis of prostate cancer.
Borkowetz A; Platzek I; Toma M; Laniado M; Baretton G; Froehner M; Koch R; Wirth M; Zastrow S
BJU Int; 2015 Dec; 116(6):873-9. PubMed ID: 25523210
[TBL] [Abstract][Full Text] [Related]
7. Magnetic Resonance Imaging-Ultrasound Fusion Targeted Prostate Biopsy in a Consecutive Cohort of Men with No Previous Biopsy: Reduction of Over Detection through Improved Risk Stratification.
Mendhiratta N; Rosenkrantz AB; Meng X; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
J Urol; 2015 Dec; 194(6):1601-6. PubMed ID: 26100327
[TBL] [Abstract][Full Text] [Related]
8. The detection of significant prostate cancer is correlated with the Prostate Imaging Reporting and Data System (PI-RADS) in MRI/transrectal ultrasound fusion biopsy.
Cash H; Maxeiner A; Stephan C; Fischer T; Durmus T; Holzmann J; Asbach P; Haas M; Hinz S; Neymeyer J; Miller K; Günzel K; Kempkensteffen C
World J Urol; 2016 Apr; 34(4):525-32. PubMed ID: 26293117
[TBL] [Abstract][Full Text] [Related]
9. A prospective comparison of MRI-US fused targeted biopsy versus systematic ultrasound-guided biopsy for detecting clinically significant prostate cancer in patients on active surveillance.
Da Rosa MR; Milot L; Sugar L; Vesprini D; Chung H; Loblaw A; Pond GR; Klotz L; Haider MA
J Magn Reson Imaging; 2015 Jan; 41(1):220-5. PubMed ID: 25044935
[TBL] [Abstract][Full Text] [Related]
10. Targeted biopsy with MRI and ultrasound improves detection of high risk prostate cancer.
Mayor S
BMJ; 2015 Jan; 350():h472. PubMed ID: 25630373
[No Abstract] [Full Text] [Related]
11. Magnetic Resonance Imaging Targeted Biopsy Improves Selection of Patients Considered for Active Surveillance for Clinically Low Risk Prostate Cancer Based on Systematic Biopsies.
Ouzzane A; Renard-Penna R; Marliere F; Mozer P; Olivier J; Barkatz J; Puech P; Villers A
J Urol; 2015 Aug; 194(2):350-6. PubMed ID: 25747105
[TBL] [Abstract][Full Text] [Related]
12. First round of targeted biopsies using magnetic resonance imaging/ultrasonography fusion compared with conventional transrectal ultrasonography-guided biopsies for the diagnosis of localised prostate cancer.
Mozer P; Rouprêt M; Le Cossec C; Granger B; Comperat E; de Gorski A; Cussenot O; Renard-Penna R
BJU Int; 2015 Jan; 115(1):50-7. PubMed ID: 24552477
[TBL] [Abstract][Full Text] [Related]
13. Prebiopsy MRI and MRI-ultrasound Fusion-targeted Prostate Biopsy in Men With Previous Negative Biopsies: Impact on Repeat Biopsy Strategies.
Mendhiratta N; Meng X; Rosenkrantz AB; Wysock JS; Fenstermaker M; Huang R; Deng FM; Melamed J; Zhou M; Huang WC; Lepor H; Taneja SS
Urology; 2015 Dec; 86(6):1192-8. PubMed ID: 26335497
[TBL] [Abstract][Full Text] [Related]
14. Perineural Invasion in Prostate Cancer Is More Frequently Detected by Multiparametric MRI Targeted Biopsy Compared With Standard Biopsy.
Gordetsky JB; Nix JW; Rais-Bahrami S
Am J Surg Pathol; 2016 Apr; 40(4):490-4. PubMed ID: 26523543
[TBL] [Abstract][Full Text] [Related]
15. Screening and detection advances in magnetic resonance image-guided prostate biopsy.
Stephenson SK; Chang EK; Marks LS
Urol Clin North Am; 2014 May; 41(2):315-26. PubMed ID: 24725492
[TBL] [Abstract][Full Text] [Related]
16. Precision of MRI/ultrasound-fusion biopsy in prostate cancer diagnosis: an ex vivo comparison of alternative biopsy techniques on prostate phantoms.
Westhoff N; Siegel FP; Hausmann D; Polednik M; von Hardenberg J; Michel MS; Ritter M
World J Urol; 2017 Jul; 35(7):1015-1022. PubMed ID: 27830373
[TBL] [Abstract][Full Text] [Related]
17. A prospective, blinded comparison of magnetic resonance (MR) imaging-ultrasound fusion and visual estimation in the performance of MR-targeted prostate biopsy: the PROFUS trial.
Wysock JS; Rosenkrantz AB; Huang WC; Stifelman MD; Lepor H; Deng FM; Melamed J; Taneja SS
Eur Urol; 2014 Aug; 66(2):343-51. PubMed ID: 24262102
[TBL] [Abstract][Full Text] [Related]
18. Prostate cancer detection using multiparametric 3 - tesla MRI and fusion biopsy: preliminary results.
Mussi TC; Garcia RG; Queiroz MR; Lemos GC; Baroni RH
Int Braz J Urol; 2016; 42(5):897-905. PubMed ID: 27532112
[TBL] [Abstract][Full Text] [Related]
19. Re: comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.
Gershman B; Karnes RJ
Eur Urol; 2015 Sep; 68(3):536-7. PubMed ID: 26282353
[No Abstract] [Full Text] [Related]
20. Re: Comparison of MR/Ultrasound Fusion-Guided Biopsy with Ultrasound-Guided Biopsy for the Diagnosis of Prostate Cancer.
Taneja SS
J Urol; 2015 Jul; 194(1):112-5. PubMed ID: 26088222
[No Abstract] [Full Text] [Related]
[Next] [New Search]
